• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Home
  • Latest
  • Videos
  • Series
  • E-Newsletters
    • Fat Tail Daily
    • James Cooper’s Mining Memo
    • The Daily Reckoning Australia
  • Categories
    • Commodities
    • Macro
    • Market Analysis
    • Small Caps
    • Technology
  • Investment Guides
  • Premium Services
  • Editors
  • About
  • Contact Us
Fat Tail Daily
Subscribe
  • Home
  • Latest
  • Videos
  • E-Newsletters
  • Premium Services
Bio Tech

Oneview Share Price Rockets 133% Higher on Samsung Deal (ASX:ONE)

Like 0

By Ryan Clarkson-Ledward, Monday, 01 February 2021

If you needed a reason to see the MedTech boom for yourself, Oneview Healthcare Plc [ASX:ONE] has certainly provided it today. The ONE share price is up 133.33% at time of writing — surging on the back of a new deal with Samsung of all companies...

If you needed a reason to see the MedTech boom for yourself, Oneview Healthcare Plc [ASX:ONE] has certainly provided it today.

The ONE share price is up 133.33% at time of writing — surging on the back of a new deal with Samsung of all companies.

Together the pair plan to provide new, digital care solutions to North America. Using software to aid bedside services for patients across the US.

Let’s explore what Oneview has to offer…

Cloud solutions for COVID-19

Oneview, as a health-focused software company, has developed Cloud Start. A package that runs exclusively on Samsung tablets, to provide virtual rounding, virtual visitation, and virtual translation.

On top of that, the enterprise-grade tier, allows for personalised education, meal orders, and other patient requests. Allowing not only for better and more seamless patient care, but also less exposure to infection risk for care providers.

As such, you can no doubt see why this is a desirable solution for hospitals grappling with COVID-19 patients. With Cloud Start already being used in four hospitals across New York.

Now though, with Samsung’s help via a distribution agreement, Oneview intends to broaden their market. Bringing their virtual care solutions to a wider portion of the US healthcare system.

As Oneview’s CEO James Fitter notes:

‘Our move to the cloud accelerates speed to market and opens new possibilities for distribution, making it faster, easier and lower-cost for end-customers to benefit from the digital platform at the bedside. Never has this need been so apparent.

‘Our partnership with Samsung provides a unique opportunity to address new virtual models of care and provide the solution for Samsung SDSA to enhance the value proposition for their reseller network.’

So, if all goes to plan, this should net Oneview a range of new customers. Hopefully at the enterprise level, too.

For investors that is obviously fantastic news. An agreement that should see revenues increasing soon. Especially given the prevalence and recognition that a company like Samsung commands.

What’s next for Oneview?

Looking ahead, the clear focus for Oneview will be on perfecting their Cloud solutions.

Ensuring they provide a best-in-class virtual platform. Giving healthcare providers and their patients the most seamless experience possible.

That will help drive engagement and usability. Allowing Oneview to not only demonstrate the usefulness of their software but perhaps even explore new uses. An avenue that investors will likely be looking for as this small company scales up its market offering.

Who knows, Oneview may even be able to explore the possibility for AI-based solutions in future. A development that is highly anticipated across the broader healthcare industry.

And if you’re on the lookout for AI stocks on the ASX, well then there is plenty of choice to choose from. Our latest report on the sector covers everything you need to know, and more, about this emerging tech sector. Including a few of our favourite stocks available to invest in right now.

For more details, check out the full report, right here.

Regards,

Ryan Clarkson-Ledward,
For Money Morning

All advice is general advice and has not taken into account your personal circumstances.

Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

Comments

Subscribe
Notify of
guest
guest
0 Comments
Ryan Clarkson-Ledward

Ryan’s Premium Subscriptions

Publication logo
Fat Tail Investment Research

Latest Articles

  • Don’t Chase the Rocket Pt. 2
    By Charlie Ormond

    Part 2 of Charlie’s view on some durable themes that exist outside of the current market hype-cycle.

  • Gold falls as uranium nears a buy zone
    By Murray Dawes

    This week, Lachlan Tierney joins Murray to discuss US stocks, vulnerable financials, falling gold and oil, and whether uranium stocks are starting to set up a new buying opportunity.

  • The Worst Commodity of All
    By James Cooper

    Former geologist, James Cooper, shines a light on the world’s most hated commodity

Primary Sidebar

Latest Articles

  • Don’t Chase the Rocket Pt. 2
  • Gold falls as uranium nears a buy zone
  • The Worst Commodity of All
  • Don’t Chase the Rocket Pt.1
  • Gold breaks a new low for 2026 – Why buying now may be your best move

Footer

Fat Tail Daily Logo
YouTube
Facebook
x (formally twitter)
LinkedIn

About

Investment ideas from the edge of the bell curve.

Go beyond conventional investing strategies with unique ideas and actionable opportunities. Our expert editors deliver conviction-led insights to guide your financial journey.

Quick Links

Subscribe

About

FAQ

Terms and Conditions

Financial Services Guide

Privacy Policy

Get in Touch

Contact Us

Email: support@fattail.com.au

Phone: 1300 667 481

All advice is general in nature and has not taken into account your personal circumstances. Please seek independent financial advice regarding your own situation, or if in doubt about the suitability of an investment.

The value of any investment and the income derived from it can go down as well as up. Never invest more than you can afford to lose and keep in mind the ultimate risk is that you can lose whatever you’ve invested. While useful for detecting patterns, the past is not a guide to future performance. Some figures contained in our reports are forecasts and may not be a reliable indicator of future results. Any actual or potential gains in these reports may not include taxes, brokerage commissions, or associated fees.

Fat Tail Logo

Fat Tail Daily is brought to you by the team at Fat Tail Investment Research

Copyright © 2026 Fat Tail Daily | ACN: 117 765 009 / ABN: 33 117 765 009 / ASFL: 323 988